Board of Directors
| Name…………………….. | Designation……………………….. | Short Description | |
|---|---|---|---|
 | Stéphane Thiroloix | Founder, President & CEO | HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN. |
 | Olivier Bohuon | Co-Founder | Chairman of the Board LEO Pharma. External Director Takeda plc. External Director Smiths Group plc. Supervisory Board Member Virbac. |
 | Thibaut Roulon | Member, BOD | Senior Investment Director – Life Sciences, Bpifrance. Graduate Ecole Centrale Paris, PhD in Molecular Biophysics P&M Curie University. |
 | Claire Poulard | Member, BOD | Principal, Omnes Capital. Master in Pharm Mgt & Biotech ESCP Europe, Master in Bioengineering & Neuroscience Innovation ESPCI. |
 | Hugues Le Bret | Member, BOD | Founder & Supervisory Board President Compte-Nickel. Adviser to CEO BNP Paribas. Prev President & CEO Boursorama. |
 | Scott Byrd | Independent Member, BOD | CEO Pioneer Tx, CoB of Acacia Pharma Group. BS in mechanical eng. & MBA Harvard University. |
 | Ed Harrigan | Independent Member, BOD | Board Mb at Acadia, Incyte and Phase Bio. Sc Advisor to Alzheon and Karuna Tx. BA St Anselm, MD Massachusetts University, Neurology Boston University. |
Executive Team
| Name…………………….. | Designation…………………….. | Short Description | |
|---|---|---|---|
| Stéphane Thiroloix | Founder, President & CEO | HEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN. |
 | Philippe Picaut | Chief Scientific Officer | Pharm D, MSc Tox, MSc Anatomopathology, American Board of Toxicology. Sr VP Neurosciences R&D, Ipsen |
 | Jens Ellrich | Chief Medical Officer | MD, PhD, Prof of neuroscience at RWTH Aachen & Aalborg University. Sapiens, WISE, EBS Technologies, BIAL, Precisis. |
 | Paola Principe-Nicolas | R&D Project Mgt | PhD in genetics and cell biochemistry. Development expertise in oncology, neurology and endocrinology. Ipsen, PNP Pharmac |
 | France Catus | Clinical Operations Manager | MD. Statistics DIU (Cesam). Ipsen Medical Dvt Dir, Clin Dvt Dir. |
 | Steve Scott | US Regulatory Officer | Founder, PDR for Pharma. Ipsen VP North American Reg Aff,Biomeasure, Pharma Dvt Resources, Sepracor, Parexel, Interferon Sciences |
 | Etienne Bienfait | Finance & Admin Manager | Engineer, Research Master in Business Mgt. Covage, Bryan Garnier |
Scientific Advisory Board
| Name…………………….. | Designation…………. | Short Description | |
|---|---|---|---|
 | Céline Greco | Chair, SAB | MD PhD. Hosp. Practitioner, Dpt of neonatal, pediatric & adult pain and palliative medicine, Hop Necker Enfants Malades, Paris, France. |
 | Ronald Levy | Member, SAB | Prof of Medicine. Stanford U Dpt of Oncology, Faisal Intl Prize, Damashek Prize, American Cancer Society’s Medal of Honor. |
 | Jean-François Bergmann | Member, SAB | Prof Therapeutics, Paris VII U. Previously : Head Intl Med & Inf Dis H. Lariboisière, expert EMA, VP ANSM Drug Auth Ctee & Transparency Ctee |
 | Philippe Arnaud | Member, SAB | Pharm D, Hosp. Pharmacist, APHP Paris. Prof, Faculty of Pharmacy, Paris. Erasmus Prof, Portugal. Prev Member of French Medicines Agency ANSM |
 | Alain Eschalier | Member, SAB | Pharmacist, Medical Doctor and Pharmacologist. Professor of Medical Pharmacology, former President of the Université d’Auvergne, France. |
 | Axel Le Cesne | Member, SAB | Assoc Prof of Medicine. Head of Medical Onclogy Hospital Unit, Gustave Roussy, France. |
 | Roy Freeman | Member, SAB | MD. Prof Neurology, Harvard Med School. Dir Cntr for Autonomic and Periph Nerve Disorders at Beth Israel Deaconess Medical Ctr, Boston, Ma. |